Point-of-Care Devices

Genomic and Personalized Medicine

Volumn 1, Issue , 2013, Pages 372-380

  Ahmed, Minhaz Uddin ^a   Brown, April S ^a   Wu, Pae C ^a  

^a Duke University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883971122     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382227-7.00032-X     Document Type: Chapter

References (52)

1. Agrawal A., Deo R., Wang G.D., Wang M.D., Nie S. Nanometer-scale mapping and single-molecule detection with color-coded nanoparticle probes. Proc Natl Acad Sci 2008, 105(9):3298-3303.
2. Ahmed M.U., Idegami K., Chikae M., Kerman K., Chaumpluk P., Yamamura S., et al. Electrochemical DNA biosensor using a disposable electrochemical printed (DEP) chip for the detection of SNPs from unpurified PCR amplicons. Analyst 2007, 132(5):431-438.
3. Alivisatos P. The use of nanocrystals in biological detection. Nat Biotechnol 2004, 22(1):47-52.
4. Amonkar S.D., Bertenshaw G.P., Chen T.-H., Bergstrom K.J., Zhao J., Seshaiah P., et al. Development and preliminary evaluation of a multivariate index assay for ovarian cancer. PLoS ONE 2009, 4(2):e4599.
5. Bergveld P. Thirty years of ISFETOLOGY: what happened in the past 30 years and what may happen in the next 30 years. Sens Actuators B Chem 2003, 88(1):1-20.
6. Bertenshaw G.P., Yip P., Seshaiah P., Zhao J., Chen T.-H., Wiggins W.S., et al. Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008, 17(10):2872-2881.
7. Biris A.S., Galanzha E.I., Li Z., Mahmood M., Xu Y., Zharov V.P. In vivo Raman flow cytometry for real-time detection of carbon nanotube kinetics in lymph, blood, and tissues. J Biomed Optics 2009, 14(2):021006.
8. Carvalhal R.F., Machado D.S., Mendes R.K., Almeida A.L.J., Moreira N.H., Piazetta M.H.O., et al. Development of a disposable amperometric biosensor for salicylate based on a plastic electrochemical microcell. Biosens. Bioelectron. 2010, 25(10):2200-2204.
9. Colotta F., Mantovani A., Speer R., Wulfkuhle J., Espina V., Aurajo R., et al. Molecular network analysis using reverse phase protein microarrays for patient tailored therapy. Adv Exp Med Biol 2008, 610:177-186.
10. Culha M., Stokes D.L., Griffin G.D., Vo-Dinh T. Application of a miniature biochip using the molecular beacon probe in breast cancer gene BRCA1 detection. Biosens Bioelectron 2004, 19(9):1007-1012.
11. de Fougerolles A., Vornlocher H.-P., Maraganore J., Lieberman J. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007, 6(6):443-453.
12. Emilien G., Ponchon M., Caldas C., Isacson O., Maloteaux J.-M. Impact of genomics on drug discovery and clinical medicine. QJM 2000, 93(7):391-423.
13. Espina V., Liotta L.A., Petricoin E.F. Reverse-phase protein microarrays for theranostics and patient tailored therapy. Meth Mol Biol 2009, 520:89-105.
14. Fan R., Vermesh O., Srivastava A., Yen B.K.H., Qin L., Ahmad H., et al. Integrated barcode chips for rapid, multiplexed analysis of proteins in microliter quantities of blood. Nat Biotechnol 2008, 26(12):1373-1378.
15. Fang Z., Kelley S.O. Direct electrocatalytic mRNA detection using PNA-nanowire sensors. Analyt Chem 2008, 81(2):612-617.
16. Fritz J., Baller M.K., Lang H.P., Rothuizen H., Vettiger R., et al. Translating biomolecular recognition into nanomechanics. Science 2000, 288(5464):316-318.
17. Gao X., Nie S. Molecular profiling of single cells and tissue specimens with quantum dots. Trends Biotechnol 2003, 21(9):371-373.
18. Gao Z., Agarwal A., Trigg A.D., Singh N., Fang C., Tung C.-H., et al. Silicon nanowire arrays for label-free detection of DNA. Analyt Chem 2007, 79(9):3291-3297.
19. Gialamas A., Yelland L.N., Ryan P., Willson K., Laurence C.O., Bubner T.K., et al. Does point-of-care testing lead to the same or better adherence to medication? A randomised controlled trial: the PoCT in General Practice Trial. Med J Aust 2009, 191(9):487-491.
20. Gibler W.B., Blomkalns A.L. Point-of-care testing for cardia biomarkers in the ED: a blueprint for implementation. Emerg Med Cardiac Res Educ Group 2006, 1:1-10.
21. Goluch E.D., Nam J.-M., Georganopoulou D.G., Chiesl T.N., Shaikh K.A., Ryu K.S., et al. A bio-barcode assay for on-chip attomolar-sensitivity protein detection. Lab Chip 2006, 6(10):1293-1299.
22. Goluch E.D., Stoeva S.I., Lee J.-S., Shaikh K.A., Mirkin C.A., Liu C. A microfluidic detection system based upon a surface immobilized biobarcode assay. Biosens Bioelectron 2009, 24(8):2397-2403.
23. Griffin T.J., Smith L.M. Single-nucleotide polymorphism analysis by MALDI-TOF mass spectrometry. Trends Biotechol 2000, 18(2):77-84.
24. Gygi S.P., Rochon Y., Franza B.R., Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 1999, 19(3):1720-1730.
25. Hill H.D., Mirkin C.A. The bio-barcode assay for the detection of protein and nucleic acid targets using DTT-induced ligand exchange. Nat Protocols 2006, 1(1):324-336.
26. Kerman K., Vestergaard M.d., Nagatani N., Takamura Y., Tamiya E. Electrochemical genosensor based on peptide nucleic acid-mediated PCR and asymmetric PCR techniques: electrostatic interactions with a metal cation. Analyt Chem 2006, 78(7):2182-2189.
27. Kerman K., Saito M., Tamiya E. Electroactive chitosan nanoparticles for the detection of single-nucleotide polymorphisms using peptide nucleic acids. Analyt Bioanalyt Chem 2008, 391(8):2759-2767.
28. Kim M.-J., Huang S.-M., Meyer U.A., Rahman A., Lesko L.J. A regulatory science perspective on warfarin therapy: a pharmacogenetic opportunity. J Clin Pharmacol 2009, 49(2):138-146.
29. Kingsmore S.F. Multiplexed protein measurement: technologies and applications of protein and antibody arrays. Nat Rev Drug Discov 2006, 5(4):310-321.
30. Krishnamoorthy G., Carlen E.T., Bomer J.G., Wijnperle D., deBoer H.L., Berg A.v.d., et al. Electrokinetic label-free screening chip: a marriage of multiplexing and high throughput analysis using surface plasmon resonance imaging. Lab Chip 2010, 10(8):986-990.
31. Lesko L. The critical path of warfarin dosing: finding an optimal dosing strategy using pharmacogenetics. Clin Pharmacol Ther 2008, 84(3):301-303.
32. Liu J., Tiefenauer L., Tian S., Nielsen P.E., Knoll W. PNA-DNA hybridization study using labeled streptavidin by voltammetry and surface plasmon fluorescence spectroscopy. Analyt Chem 2005, 78(2):470-476.
33. Mathivanan S., Ahmed M., Ahn N.G., Alexandre H., Amanchy R., Andrews P.C., et al. Human Proteinpedia enables sharing of human protein data. Nat Biotechnol 2008, 26(2):164-167.
34. Mitani Y., Lezhava A., Kawai Y., Kikuchi T., Oguchi-Katayama A., Kogo Y., et al. Rapid SNP diagnostics using asymmetric isothermal amplification and a new mismatch-suppression technology. Nat Meth 2007, 4(3):257-262.
35. Mitani Y., Lezhava A., Sakurai A., Horikawa A., Nagakura M., Hayashizaki Y., et al. Rapid and cost-effective SNP detection method: application of SmartAmp2 to pharmacogenomics research. Pharmacogenomics 2009, 10(7):1187-1197.
36. Nichkova M., Dosev D., Gee S.J., Hammock B.D., Kennedy I.M. Multiplexed immunoassays for proteins using magnetic luminescent nanoparticles for internal calibration. Analyt Biochem 2007, 369(1):34-40.
37. Oh J., Chang Y.W., Kim H.J., Yoo S., Kim D.J., Im S., et al. Carbon nanotube-based dual-mode biosensor for electrical and surface plasmon resonance measurements. Nano Lett 2010, 10(8):2755-2760.
38. Riehemann K., Schneider S., Luger T., Godin B., Ferrari M., Fuchs H. Nanomedicine - Challenge and perspectives. Angew Chem Int Ed 2009, 48(5):872-897.
39. Ross P., Hall L., Smirnov I., Haff L. High level multiplex genotyping by MALDI-TOF mass spectrometry. Nat Biotechnol 1998, 16(13):1347-1351.
40. Sanvicens N., Marco M.P. Multifunctional nanoparticles: properties and prospects for their use in human medicine. Trends Biotechnol 2008, 26(8):425-433.
41. Schöning M.J., Poghossian A. Recent advances in biologically sensitive field-effect transistors (BioFETs). Analyst 2002, 127(9):1137-1151.
42. Shumaker-Parry J.S., Aebersold R., Campbell C.T. Parallel, quantitative measurement of protein binding to a 120-element double-stranded DNA array in real time using surface plasmon resonance microscopy. Analyt Chem 2004, 76(7):2071-2082.
43. Sorger P.K. Microfluidics closes in on point-of-care assays. Nat Biotechnol 2008, 26(12):1345-1346.
44. Stern E., Vacic A., Rajan N.K., Criscione J.M., Park J., Ilic B.R., et al. Label-free biomarker detection from whole blood. Nat Nanotechnol 2009, 5:138-142.
45. Sturgeon C.M., Hoffman B.R., Chan D.W., Ch'ng S.-L., Hammond E., Hayes D.F., et al. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in clinical practice: quality requirements. Clin Chem 2008, 54(8):e1-10.
46. Thaxton C.S., Elghanian R., Thomas A.D., Stoeva S.I., Lee J.-S., Smith N.D., et al. Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy. Proc Natl Acad Sci 2009, 106(44):18437-18442.
47. Tomizaki K.Y., Usui K., Mihara H. Protein-detecting microarrays: current accomplishments and requirements. Chem Biochem 2005, 6(5):782-799.
48. Weinshilboum R.M., Wang L. Pharmacogenetics and pharmacogenomics: development, science, and translation. Ann Rev Genomics Hum Genet 2006, 7(1):223-245.
49. Wu P., Castner D.G., Grainger D.W. Diagnostic devices as biomaterials: a review of nucleic acid and protein microarray surface performance issues. J Biomat Sci, Polymer Ed 2008, 19(6):725-753.
50. Wulfkuhle J.D., Speer R., Pierobon M., Laird J., Espina V., Deng J., et al. Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy. J Proteome Res 2008, 7(4):1508-1517.
51. Yu X., Schneiderhan-Marra N., Hsu H.-Y., Bachmann J., Joos T.O. Protein microarrays: effective tools for the study of inflammatory diseases. Meth Mol Biol 2009, 577:199-214.
52. Yu X., Schneiderhan-Marra N., Joos T.O. Protein microarrays for personalized medicine. Clin Chem 2010, 56(3):376-387.